SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-006148
Filing Date
2024-04-29
Accepted
2024-04-29 17:06:26
Documents
20
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A iova-20240611xdef14a.htm   iXBRL DEF 14A 2035642
2 GRAPHIC iova-20240611xdef14a_a002.jpg GRAPHIC 15019
3 GRAPHIC iova-20240611xdef14a_a008.jpg GRAPHIC 46499
4 GRAPHIC iova-20240611xdef14a_a019.jpg GRAPHIC 62156
5 GRAPHIC iova-20240611xdef14a_a020.jpg GRAPHIC 52529
6 GRAPHIC iova-20240611xdef14a_bg001.jpg GRAPHIC 227091
7 GRAPHIC iova-20240611xdef14a_bg002.jpg GRAPHIC 155314
  Complete submission text file 0001558370-24-006148.txt   5193475

Data Files

Seq Description Document Type Size
8 EX-101.SCH iova-20240611.xsd EX-101.SCH 7189
9 EX-101.DEF iova-20240611_def.xml EX-101.DEF 11081
10 EX-101.LAB iova-20240611_lab.xml EX-101.LAB 16738
11 EX-101.PRE iova-20240611_pre.xml EX-101.PRE 8355
23 EXTRACTED XBRL INSTANCE DOCUMENT iova-20240611xdef14a_htm.xml XML 653888
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 24892481
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)